In 2005, under the tutelage and guidance of Macrogen, Inc. (Korea), Macrogen Corp. opened its laboratory in Rockville, Maryland to serve Sanger DNA sequencing needs of researchers. While consistently growing geographically and expanding into Next Generation Sequencing (NGS), Macrogen Clinical Lab was formed to offer top and distinguished clinical sequencing (CLI-Seq) services to U.S. patients and hospitals in 2012.
Macrogen Inc., the parent company of Macrogen Corp., was established in 1997 and has provided many genetic technology services (NGS, capillary sequencing, microarray, mouse, oligo synthesis, mouse, and bioinformatics) to over 100 countries for 20 years. As a result, we’ve been the leading biotech company in the scientific services market. Macrogen also publishes numerous articles in leading journals such as Nature and Genome Research.
Macrogen Corp. provides CLIA-licensed and top quality services through the research and clinical experiences of our genetic and medical experts.
Our director is Dr. Carlos J. Ruiz.